Latest filing published 02 Feb 2026 for Viemed Healthcare, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jerome Cambre in Viemed Healthcare, Inc., where the filings describe the role as senior executive. In total, 15 filings cover trades dated from 9 May 2021 to 29 January 2026.
On the market, this insider has only sold: 1 sale, €9,888 in total. Outside the open market, there are 14 option exercises.
The newest entry dates from 2 February 2026: an option exercise, in Viemed Healthcare, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations